Pages that link to "Q28569826"

The following pages link to Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase (Q28569826):

Displaying 23 items.

• The glucose-6-phosphatase system (Q24533844) (← links)
• Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes (Q28348998) (← links)
• Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling (Q33178151) (← links)
• Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats (Q33179366) (← links)
• New approaches in the treatment of type 2 diabetes (Q34014393) (← links)
• New drug targets for type 2 diabetes and the metabolic syndrome (Q34105009) (← links)
• In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery (Q34163311) (← links)
• Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease (Q34654019) (← links)
• New pharmacologic agents for diabetes (Q35087359) (← links)
• Novel targets and therapeutic strategies for type 2 diabetes (Q35114594) (← links)
• Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions. (Q39380440) (← links)
• Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors (Q40441358) (← links)
• Functional silencing of hepatic microsomal glucose-6-phosphatase gene expression in vivo by adenovirus-mediated delivery of short hairpin RNA. (Q40593623) (← links)
• Instant coffee extract with high chlorogenic acids content inhibits hepatic G-6-Pase in vitro, but does not reduce the glycaemia (Q40955253) (← links)
• Inhibition of autophagic proteolysis by inhibitors of phosphoinositide 3-kinase can interfere with the regulation of glycogen synthesis in isolated hepatocytes (Q43002527) (← links)
• Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein (Q43952067) (← links)
• Thielavins as glucose-6-phosphatase (G6Pase) inhibitors: producing strain, fermentation, isolation, structural elucidation and biological activities (Q44290346) (← links)
• Future targets in the treatment of type 2 diabetes (Q44896352) (← links)
• Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR(-)) by the glucose-6-phosphate translocase inhibitor S 3025. (Q45712730) (← links)
• Simultaneous quantification of labeled (2)H5-glycerol, (13)C6-glucose, and endogenous D-glucose in mouse plasma using liquid chromatography tandem mass spectrometry. (Q53538996) (← links)
• Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines (Q73064880) (← links)
• CJ-21,164, a New D-Glucose-6-phosphate Phosphohydrolase Inhibitor Produced by a Fungus Chloridium sp. (Q78429007) (← links)
• Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin (Q83921100) (← links)